Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04908943 · ClinicalTrials.gov registry record · NA
RENEW Scleroderma: A Peer-Mentored, Web Intervention for Resilience-based, Energy Management to Enhance Wellbeing and Fatigue
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 174
- Enrollment target
NCT04908943 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 174 participants.
The verdict
NCT04908943, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 174 participants
- Enrollment target
Study Summary
The researchers seek to understand if the Resilience-based, Energy Management to Enhance Wellbeing and Fatigue (RENEW) program helps with scleroderma symptom management and disease burden. The researchers think that those participants who receive the intervention will have clinically meaningful changes of symptom management and disease burden.
Interventions
- BEHAVIORAL RENEW
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2021-08-28 |
| Est. Completion | 2023-05-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04908943
The ClinicalTrials.gov registry entry for NCT04908943 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RENEW is the first listed.
NCT04908943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04908943 about?
NCT04908943 is a clinical study titled "RENEW Scleroderma: A Peer-Mentored, Web Intervention for Resilience-based, Energy Management to Enhance Wellbeing and Fatigue". The researchers seek to understand if the Resilience-based, Energy Management to Enhance Wellbeing and Fatigue (RENEW) program helps with scleroderma symptom management and disease burden. The researchers think that those participants who receive the intervention will have clinically meaningful chan...
What is the current status of trial NCT04908943?
This trial is currently completed. It is a NA study. The enrollment target is 174 participants. The study started on 2021-08-28. Estimated completion is 2023-05-29.
What interventions are being tested in trial NCT04908943?
The interventions under investigation include: RENEW (BEHAVIORAL).
Who is sponsoring clinical trial NCT04908943?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.